Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-24

Novel drug targets specific to persistent (latent) tuberculosis infection : crystallisation, structure determination and functional studies (persistent tb)

Objective

M.tuberculosis remains the leading cause of death worldwide from an infectious agent and is responsible for nearly three million deaths every year. About one-third of the world population is infected with M. tuberculosis, 10 % of which will develop the disease at some point in their lives. Currently available antibiotics are completely ineffective against persistent bacteria The aim of our project is to solve the 3-D structure of several sterilising drug targets, some of which have been identified by us recently. This would lead to the development of totally novel antibiotics, with completely new modes of action, which are active against stationary phase persistent Mycobacterium tuberculosis. These antibiotics will shorten the duration of chemotherapy and/or synergies with existing antibiotics in humans by reducing bacterial subpopulations, which are tolerant to conventional antimicrobials and thus control reactivation of TB.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

LIONEX DIAGNOSTICS & THERAPEUTICS GMBH
EU contribution
No data
Address
Mascheroder Weg 1
38124 BRAUNSCHWEIG
Germany

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (4)

My booklet 0 0